Donanemab in Early Alzheimer's Disease. Reply
N Engl J Med
.
2021 Aug 12;385(7):667.
doi: 10.1056/NEJMc2109455.
Authors
Mark A Mintun
1
,
Alette M Wessels
1
,
John R Sims
1
Affiliation
1
Eli Lilly, Indianapolis, IN mintun@lilly.com.
PMID:
34379934
DOI:
10.1056/NEJMc2109455
No abstract available
Publication types
Letter
Comment
MeSH terms
Alzheimer Disease*
Disease Progression
Humans